564 related articles for article (PubMed ID: 16080080)
1. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
2. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
3. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
[TBL] [Abstract][Full Text] [Related]
5. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
[TBL] [Abstract][Full Text] [Related]
6. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
[TBL] [Abstract][Full Text] [Related]
7. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients.
Achour W; Guenni O; Malbruny B; Canu A; Leclercq R; Hassen AB
J Antimicrob Chemother; 2004 Jul; 54(1):117-21. PubMed ID: 15190021
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
[TBL] [Abstract][Full Text] [Related]
10. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
11. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
[TBL] [Abstract][Full Text] [Related]
12. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
Colakoglu S; Alacam R; Hascelik G
Scand J Infect Dis; 2006; 38(6-7):456-9. PubMed ID: 16798693
[TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany.
Brandt CM; Honscha M; Truong ND; Holland R; Hövener B; Bryskier A; Lütticken R; Reinert RR
Microb Drug Resist; 2001; 7(2):165-70. PubMed ID: 11442342
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
16. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
Acikgoz ZC; Gocer S; Tuncer S
J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
[TBL] [Abstract][Full Text] [Related]
17. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.
Opavski N; Gajic I; Borek AL; Obszańska K; Stanojevic M; Lazarevic I; Ranin L; Sitkiewicz I; Mijac V
Infect Genet Evol; 2015 Jul; 33():246-52. PubMed ID: 25976381
[TBL] [Abstract][Full Text] [Related]
20. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
Rodríguez C; Rojas P; Wozniak A; Kalergis AM; Cerón I; Riedel I; Román JC; Villarroel LA; Berríos X; Bavestrello L; García P
Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
